News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

Biotech/Pharma - Mergers and Acquisitions
Amgen (AMGN) Rumored to be Another Medivation (MDVN) Suitor 5/6/2016
Luye Medical Welcomes Australia's Healthe Care To Its Group, Leading The Way For Group Expansion In Asia 5/5/2016
ReWalk (RWLK) Release: Department Of Veterans Affairs Purchases 20 Rewalk Systems To Support National Multi-Center Trial Assessing Personal Exoskeleton System Use 5/5/2016
AMRI (AMRI) Bags Euticals in $358 Million Cash-Stock Deal 5/5/2016
Sanofi (SNY) Heats Up Medivation (MDVN) Bid With Letter Threatening a Hostile Takoever 5/5/2016
Sanofi (SNY) CEO Sees a Strong Strategic Fit with Medivation (MDVN) 5/5/2016
Medivation (MDVN) Reiterates Rejection of Sanofi (SNY)'s $9.3 Billion Bid 5/5/2016
Bay Area’s Medivation (MDVN) Shores Up Defenses as Pfizer (PFE) Rumored to Join Sanofi (SNY) in Acquisition Bid 5/4/2016
Biogen (BIIB)'s Hemophilia Spinoff Suggests M&A Activity Could Be On the Horizon 5/4/2016
IMS Health, Quintiles (Q) to Merge to Form $23 Billion Power House 5/4/2016
Miroculus Acquires Kapplex To Advance Diagnostics For Complex Diseases 5/4/2016
Bio-Techne (TECH) Acquires Access To B-MoGen Biotechnologies' Gene Editing Technology 5/4/2016
Halyard Health Announces First Quarter 2016 Results Completes Acquisition Of CORPAK MedSystems 5/4/2016
Ligand (LGND) Acquires Portfolio Of Synthetic Royalty And Milestone Rights From Cormatrix Cardiovascular For $17.5 Million 5/4/2016
Why a Medivation (MDVN) Takeover Just Got a Little Tougher for Potential Suitors Like AstraZeneca PLC (AZN), Pfizer (PFE) and Sanofi (SNY) 5/3/2016
Marina Biotech (MRNA) Calls Off Sale of Its Nucleic Acid Therapeutic Assets to Microlin Bio 5/3/2016
As Sarepta (SRPT) And Valeant (VRX) Exit Hearings, Biotech Steps Into M&A 5/3/2016
Precision For Medicine Acquires Applied Immunology 5/3/2016
Axiogenesis Secures Major Funding For Its Expansion Course 5/3/2016
Marina Biotech (MRNA) Acquires Late-Stage Program from Turing in $95 Million Deal 5/3/2016
Pfizer (PFE) Rumored to be Selling Its Hospira Pumps Division, With Smiths Group, Fresenius SE and Pamplona Capital Bidding 5/3/2016
PE Firm Snaps Up Symmetry Surgical in $140.3 Million Deal 5/3/2016
Abbott (ABT) Tries to Back Out of $5.8B Alere (ALR) Deal, But Alere Says It’s Still On 5/2/2016
Neogen Corporation (NEOG) Acquires Preserve International And Tetradyne 5/2/2016
Letter Of Intent To Acquire NovaRx Corporation Expires; Viropro Inc. (VPRO) Appoints New Slate Of Officers 5/2/2016
Cipher Pharma (DND.TO) Acquires Worldwide Rights To Dalhousie University's Investigational Tattoo Removal Cream 5/2/2016
Veristat, Inc. Expands Its Clinical Operations Into Europe 5/2/2016
Sinocare Coughs Up $200 Million Cash for PTS Diagnostics 5/2/2016
4SC AG (VSC.F) Sells Operations Of Its Discovery Division 4/29/2016
Medivation (MDVN) Says No! to Sanofi (SNY)'s $9.3 Billion Hostile Bid 4/29/2016
AbbVie (ABBV) Pays $5.8 Billion+ for Bay Area's Stemcentrx, Which Has Ties to Paypal and SpaceX Investors 4/29/2016
Medivation (MDVN)'s Road from Penny Stock to $9.3 Billion M&A Target 4/29/2016
AstraZeneca PLC (AZN) Stays Mum on M&A, Says “No Comment” to Medivation (MDVN) Bid 4/29/2016
Sanofi (SNY) Makes Hostile $9.3 Billion Bid for Bay Area’s Medivation (MDVN) 4/29/2016
Stryker (SYK) Coughs Up $52 Million for Stanmore Implants 4/29/2016
Alere (ALR) Obtains Requisite Lender Approval For Extension To File Form 10-K; Announces Certain Developments Relating To The Pending Merger Transaction With Abbott (ABT) 4/29/2016
Abbott (ABT)'s $25 Billion Bid for St. Jude Medical (STJ) Raises Questions About Pending Alere (ALR) Deal 4/28/2016
The M&A Rumor Mill Points to Gilead (GILD) Acquiring Intercept Pharma (ICPT) 4/28/2016
Johnson & Johnson Consumer Snaps Up New Jersey's NeoStrata's for Undisclosed Sum 4/27/2016
Neogen Corporation (NEOG) Acquires Brazilian Animal Genomics Company 4/27/2016
Toshiba Got the Cash for Its Medical Biz Before the Deal Closed 4/27/2016
Nokia Bets on Digital Health with $190 Million Buy 4/27/2016
Rumors Surface Again About AstraZeneca PLC (AZN), Sanofi (SNY) or AbbVie (ABBV) Acquiring Medivation (MDVN) 4/27/2016
Ironwood (IRWD) to Fork Over Up to $256 Million Plus Royalties to AstraZeneca PLC (AZN) for U.S. Rights to Gout Drug 4/26/2016
Novartis AG (NVS) Mulls Over Selling $14 Billion Roche (RHHBY) Stake to Potentially Free Up Cash for New Deals 4/26/2016
MD Anderson Cancer Center To Acquire Elekta Linear Accelerators And Other Radiotherapy Solutions 4/26/2016
DNA 2.0, Inc. Acquires MIGS To Add Antibody Production Capabilities 4/26/2016
Alere (ALR) Received Notice of Default from Group of Bondholders 4/26/2016
Bay Area’s Relypsa (RLYP) Stock Pops (Again) on More Buyout Rumors 4/25/2016
Allergan (AGN) Makes Another Deal, Bags Boston's Topokine for $85 Million+ 4/25/2016
Aytu BioScience Enters $2 Billion Testosterone Replacement Market With Acquisition Of U.S. Commercial Rights To Natesto 4/25/2016
Zimmer Biomet Enters Into Definitive Agreement To Acquire Cayenne Medical 4/25/2016
Singapore-Based Luye Medical Group Completes Acquisition Of Healthe Care, Australia's Third Largest Private Healthcare Group 4/25/2016
NOVACYT Raises €7.75 Million To Complete The Acquisition Of Primerdesign Ltd 4/25/2016
Immune Therapeutics Signs Binding Letter Of Intent To Acquire Chinese CAR-T Technology And Clinical Data 4/25/2016
Biogen (BIIB), Regeneron (REGN) and Valeant (VRX) Rank High as Potential Takeover Targets for Allergan (AGN) 4/22/2016
Concordia (CXR.TO) Stock Rockets on Rumors of a Blackstone Buyout 4/22/2016
Alere (ALR) Stock Falls as Abbott (ABT) CEO Declines to Comment and Confirm $6 Billion Deal 4/22/2016
Nexeon MedSystems, Inc. Announces Acquisition Of Neuromodulation IP From Health Wildcatters Graduate Neurotek Medical 4/22/2016
Aptuit LLC Announces Acquisition Of Exquiron 4/21/2016
Bionik Laboratories Announces Closing Of Acquisition Of Interactive Motion Technologies Inc. 4/21/2016
Becton, Dickinson and Company (BDX) Divests Vertebral Augmentation Solutions Business To Stryker (SYK) 4/21/2016
Becton, Dickinson and Company (BDX) Divests Vertebral Augmentation Solutions Business to Stryker (SYK) for Undisclosed Amount 4/21/2016
Nanoantibiotics Acquires Company Developing Novel Therapies For Liver Disease 4/20/2016
Auris Surgical Robotics Snaps Up Bay Area's Hansen Medical (HNSN) in $80 Million Deal 4/20/2016
Allergan (AGN)'s Potential Shopping List Expands 4/19/2016
Covered in $30 Billion Debt, Embattled Valeant (VRX) Mulls Over Which Assets to Sell 4/19/2016
A Week After Medivation (MDVN) Rumored to Snub Sanofi (SNY) Bid, AstraZeneca PLC (AZN) in Talks to Make Its Own $10 Billion Offer 4/19/2016
Avioq Announces the Completion Of Its Acquisition By Oriental Ocean Sci-tech Co., Ltd. 4/19/2016
Recipharm AB Creates A Global CDMO Leader Through SEK 1.7 Billion Strategic Acquisitions In The US, Sweden And India 4/18/2016
InfuSystem, Inc. (IFLO) Agrees To Acquire Infusion Pump Assets From InfusAID, LLC 4/18/2016
Tricol International Group Limited Completes Asset Acquisition Of HemCon Medical 4/18/2016
China’s Venus Medtech Snaps Up Transcatheter Technologies 4/18/2016
PROMETHERA Biosciences S.A./N.V. Acquires Key Assets Of Cytonet LLC To Create The Global Leader In Regenerative Medicine And Cell Therapy For Liver Diseases 4/18/2016
Bay Area's Carbylan to Suspend Clinical Development of Hydros-TA and Slash Jobs to Conserve Cash 4/15/2016
Promising Hep B Drug Makes SoCal's Arrowhead Pharma (ARWR) a Pretty Target for Gilead (GILD) and Other Big Companies 4/15/2016
3 Biotechs Might Have M&A Targets On Their Backs 4/15/2016
If Pfizer (PFE) Wants to Buy, Here’s a Shopping List 4/15/2016
Embattled Valeant (VRX) Working with Banks to Review Options Amid Interest from Buyout Firms 4/15/2016
OSE Pharma And Effimune Announce The Signing Of The Merger Treaty To Create OSE Immunotherapeutics 4/15/2016
Elorac, Inc. Acquires Gideon Pharma 4/15/2016
WuXi AppTec Acquires CRELUX GmbH 4/15/2016
Advent, Baxter International (BAX) Preparing Bids for Private Indian Drugmaker Gland Pharma 4/15/2016
New Jersey's Catalent (CTLT) Jumps on Rumors of Lonza Group (LZAGY.PK)'s Takeover Bid 4/14/2016
After Exploring Strategic Alternatives, Synta (SNTA) Agrees to Merge with Madrigal to Create Leading Cardio-Metabolic Diseases and NASH Company 4/14/2016
Bay Area’s Medivation (MDVN) Stock Pops 11% After Rumors It Rejected A Sanofi (SNY) Acquisition Bid 4/14/2016
Ethicon (JNJ) Announces Completion Of Acquisition Of NeuWave Medical 4/14/2016
Novogene Establishes First U.S. Genomic Sequencing Center Located At UC Davis; Acquires Second Illumina (ILMN) Hi-Seq X Ten System 4/14/2016
CryoLife (CRY) Exercises Right to Acquire PhotoFix Bovine Pericardium Patch From Genesee BioMedical 4/14/2016
While Exploring Sale of Its Hemophilia Unit, Some Speculate Biogen (BIIB) Might be Prepping to Buy or be Acquired 4/13/2016
Fresh Off Its $1.2 Billion Deal, Gilead (GILD) Has Cash to Go Shopping Again 4/13/2016
The Female Health Company And Aspen Park Pharmaceuticals To Discuss The Proposed Merger 4/13/2016
BUCHI Labortechnik AG Acquires Flash Chromatography And ELSD Product Lines From Grace 4/12/2016
Sources Reveal Biogen (BIIB) is Exploring Sale of Hemophilia Assets 4/12/2016
Incoming Bayer (BAY) CEO Has Big Plans to Beef Up Animal Health Unit with Deals and Acquisitions 4/12/2016
EUSA Pharma Announces Acquisition Of Global Rights To Next Generation Oncology Supportive Care Product Arcoral Tab From Arcoral Pharma 4/12/2016
Halyard Health Shells Out $174 Million for CORPAK MedSystems 4/12/2016
The Valence Group Advises Eurazeo On Its Acquisition Of Novacap From Ardian 4/12/2016
Bay Area’s Relypsa (RLYP) Stock Pops At Sale Rumors While Waiting For Potential AstraZeneca PLC (AZN) Competition 4/11/2016
Ossur (OSSR) Coughs Up $39 Million for Touch Bionics 4/11/2016
Stryker (SYK) Acquires Safewire Product Portfolio For Use In Minimally-Invasive (MIS) Spine Procedures 4/11/2016
Recipharm AB Completes Acquisition Of A Majority Stake In Indian CMO Nitin Lifesciences 4/11/2016
Valeant (VRX)’s Ackman Says Company Will Not Sell Bausch & Lomb 4/8/2016
Mach 7 Technologies And 3D Medical Complete Merger 4/8/2016
Diversis Capital Acquires Caligor Rx, A Leader In Clinical Trial Supply And Logistics Services 4/8/2016
Allergan (AGN) Chief Brent Saunders On Failed Pfizer (PFE) Deal And Why He's Not Like Valeant (VRX) 4/8/2016
Nixed Pfallergan Deal Has Investors Wondering if Allergan (AGN) Might Target Biogen (BIIB) 4/7/2016
Pfizer (PFE) Formally Calls Off $160 Billion Allergan (AGN) Deal 4/7/2016
Why Biogen (BIIB) May Not be Allergan (AGN)'s Cup of Tea 4/7/2016
Shire (SHPG) Not Spooked by Pfallergan Breakup, Remains Committed to Baxalta (BXLT) 4/7/2016
Two Buys Make Adavium the Largest Brazilian Medical Equipment and Diagnostics Company, Nabs $21 Million 4/7/2016
Pfizer (PFE) Inside Source Says Company Considering Abandoning Allergan (AGN) Deal 4/6/2016
Twist Bioscience Acquires Genome Compiler To Add Gene Design Capabilities 4/6/2016
Ampronix Assumes Specific Perkins Healthcare Technologies Assets 4/6/2016
BioChain Acquires China Rights To Epigenomics AG' Lung Cancer IVD 4/6/2016
Pragma Pharmaceuticals, LLC Announces Acquisition Of Keflex 4/6/2016
U.S. Treasury Drops Bomb on Tax Inversion Deals, Threatens Pfizer (PFE)-Allergan (AGN) Merger 4/6/2016
Companies Allergan (AGN) Could Buy if Deal with Pfizer (PFE) Falls Through 4/6/2016
Why SoCal's Acadia (ACAD) May Be a Perfect Takeover Target for Biogen (BIIB) 4/5/2016
Sterigenics Scoops Up Nelson Laboratories for Undisclosed Sum 4/5/2016
DanDrit Biotech USA Inc. Announces The Purchase Of OncoSynergy 4/5/2016
Medidata Solutions, Inc. Acquires Intelemage, A Global Leader In Managing And Transferring Medical Images And Clinical Data 4/4/2016
Two Drugmakers Johnson & Johnson (JNJ) May Consider Scooping Up 4/4/2016
Repligen (RGEN) Buys Germany's Atoll GmbH in Cash and Stock Deal Worth $22.5 Million 4/4/2016
Citius Pharma Completes Acquisition Of Leonard-Meron Biosciences 4/4/2016
ANI Pharma Closes Acquisition Of Inderal LA Assets 4/4/2016
Vantage Oncology Announces Successful Completion Of Acquisition By McKesson (MCK) 4/4/2016
Charles River Laboratories (CRL) Completes the Acquisition Of WIL Research 4/4/2016
Moberg Pharma AB (Formerly known as Moberg Derma) Completes Divestment Of Three Brands For $10.4 Million 4/4/2016
Bristol-Myers Squibb (BMY) Completes Previously Announced Acquisition Of Padlock Therapeutics 4/4/2016
McKesson (MCK) Completes The Acquisitions Of Biologics, Inc. (NC) And Biologics 4/4/2016
MediGene AG (MDGEF.PK) Sells Partial Stake In Immunocore 4/4/2016
Gilead (GILD) Finally Makes a Buy, Snaps Up Massachusetts' Nimbus Apollo in $1.2 Billion Deal 4/4/2016
San Francisco's Medivation (MDVN) Hires J.P. Morgan to Head Off Acquisition Attempts 4/1/2016
For a Possible Gilead (GILD)-Celgene (CELG) Deal, Let Us Count the Ways 4/1/2016
BioTelemetry Announces The Acquisition Of The Epatch Division Of DELTA Danish Electronics, Light And Acoustics 4/1/2016
Thermo Fisher Scientific (TMO) Completes Acquisition Of Affymetrix (Santa Clara, California) (AFFX) Following Approval Of Transaction By Affymetrix Stockholders 4/1/2016
Luye Pharma Group Ltd. Bids To Acquire France's Ethypharm In Deal Worth Up To $900 Million 4/1/2016
Mallinckrodt (MNK) Rumored to be Eyeing Sale of Nuclear Imaging Unit, Biz Could Fetch $800 Million to $1 Billion 3/31/2016
Brammer Bio Formed Through Merger Of Brammer Biopharmaceuticals And Florida Biologix 3/31/2016
Wuhan Humanwell Acquires U.S. Generic Drugmaker for $550 Million 3/30/2016
As Flailing Valeant (VRX) Pushes Back Earnings Deadlines, Bausch & Lomb Sale Potentially on the Table 3/30/2016
Sun Pharma (SUNPHARMA.NS) Snaps Up 14 Japanese Brands From Novartis AG (NVS) in $293 Million Deal 3/30/2016
DiaSorin S.p.A. Shells Out $300 Million for Quest Diagnostics (DGX)'s Focus Diagnostics 3/30/2016
Trinity Medical Devices Acquires Neonatal Product Line From CASMED (CASM) 3/30/2016
QIAGEN N.V. (QGEN) Makes $100 Million Bid to Buy Exiqon A/S 3/30/2016
CASMED (CASM) Sells Neonatal Intensive Care Disposables Product Line 3/30/2016
Pfizer (PFE) And Allergan (AGN) Receive Request For Additional Information From FTC Regarding Proposed Combination 3/30/2016
Centrexion Expands Pain Pipeline With Acquisition Of Three New Analgesic Candidates From Boehringer Ingelheim 3/30/2016
Origin Withdraws $17.00 Per Share All-Cash Offer For Affymetrix (Santa Clara, California) (AFFX) 3/29/2016
Thermo Fisher Scientific (TMO) Agrees With Affymetrix (Santa Clara, California) (AFFX) That Merger Agreement Remains Superior 3/29/2016
Alten Calsoft Labs Acquires A Niche CRO Services Company PVR Technologies To Strengthen Its Healthcare And Life Sciences Business 3/29/2016
BioTelemetry Coughs Up $16 Million for VirtualScopics 3/28/2016
Onxeo Announces Closing Of DNA Therapeutics Acquisition 3/28/2016
Yantai Dongcheng Acquires China Ops Of Global Medical Solutions For $70 Million 3/28/2016
Meridian Bioscience (VIVO) Pays $66 Million for Magellan Diagnostics 3/25/2016
PuraCap Pharmaceutical Announces Acquisition Of Blu Pharmaceuticals And Blu Caribe 3/24/2016
Centene Corporation Completes Acquisition Of Health Net, Inc. 3/24/2016
Affymetrix (Santa Clara, California) (AFFX) To Engage In Discussions With Origin Technologies 3/24/2016
Bristol-Myers Squibb (BMY) Snaps Up Padlock Therapeutics in Deal Up to $600 Million, Locking Up Rheumatoid Arthritis Program 3/24/2016
Origin Technologies and Thermo Fisher Scientific (TMO) in Acquisition Love Triangle with Affymetrix (Santa Clara, California) (AFFX) 3/23/2016
After Oncology Trial Failures, Investors Urge Gilead (GILD) to Buy, Buy, Buy 3/23/2016
Eiger Biopharma Closes Merger With Celladon (CLDN) 3/23/2016
Affymetrix (Santa Clara, California) (AFFX) Determines Unsolicited Proposal From Origin Technologies Could Lead To Superior Proposal; Adjourns Special Stockholder Meeting On Thermo Fisher Scientific (TMO) Merger Vote Until March 31, 2016 3/23/2016
Thermo Fisher Scientific (TMO) Remains Confident That Origin Technologies’ Proposal Is Not Likely To Result In A Superior Proposal 3/23/2016
NDA Group And PharmApprove Announce Merger 3/22/2016
LakePharma Partners With Ampersand, Acquires Blue Sky BioServices 3/22/2016
Thermo Fisher Scientific (TMO) Issues Open Letter to Affymetrix (Santa Clara, California) (AFFX) Stockholders 3/22/2016
Bone Medical Ltd Announces Acquisition Of US-based Botanix Pharmaceuticals 3/22/2016
Precision For Medicine To Acquire ACT Oncology 3/22/2016
DNA Diagnostics Center Announces Acquisition Of All About Truth DNA Services 3/22/2016
Biotie Release: Acorda (ACOR) Supplements The Tender Offer Document Relating To The Voluntary Public Tender Offer On 22 March 2016 3/22/2016
Zymeworks Completes Acquisition Of Kairos Therapeutics Creating A Leader In Biologics Drug Discovery And Development 3/22/2016
Origin Provides Additional Information To Affymetrix (Santa Clara, California) (AFFX) Board 3/22/2016
Presidential Contender Bernie Sanders Asks the U.S. Treasury to Block Pfizer (PFE)'s Major Tax Evasion 3/22/2016
Tekni-Plex To Acquire Sancap Liner Technology 3/21/2016
CryoLife (CRY) Announces Sale of ProCol Distribution Rights And Purchase Option To LeMaitre Vascular, Inc. 3/21/2016
Bio-Techne (TECH) Agrees To Acquire Zephyrus Biosciences, Inc. 3/21/2016
Affymetrix (Santa Clara, California) (AFFX) Rejects $1.5 Billion Rival Takeover Bid, Favors Thermo Fisher Scientific (TMO) 3/21/2016
Ex-Affymetrix (Santa Clara, California) (AFFX) Execs Offer to Buy Former Employer for $1.5B 3/21/2016
After Mixed Clinical Trial Results, Bay Area’s Carbylan Engages Wedbush PacGrow to Evaluate Options 3/18/2016
Scandal-Plagued Toshiba Inks Deal to Sell Medical Biz to Canon (CAJ) for $5.9 Billion 3/18/2016
Omnis Pharma And Magnis Therapeutics Merge To Form Vyriad, A Clinical-Stage Oncolytic Immunovirotherapy Development Company 3/18/2016
Sarepta (SRPT) Chairman and Two Directors Scoop Up $2.5 Million Worth of Shares 3/18/2016
Riverside Partners' Portfolio Company, BioAgilytix Labs, Accelerates Global Expansion With The Acquisition Of German Player, IPM Biotech 3/18/2016
AstraZeneca PLC (AZN) Snaps Up All Rights to Orexo (ORXOF)'s OX-CLI Project 3/17/2016
CIVCO Medical Solutions Acquires PCI Medical 3/17/2016
ImmunogenX Acquires The Assets Of Alvine Pharmaceuticals, Inc. 3/16/2016
Grunenthal To Acquire Almirall de Mexico, S.A. de C.V. 3/16/2016
Gyros AB And Protein Technologies Merge To Form Gyros Protein Technologies AB 3/16/2016
UK's Vectura (VEC.L) Buys Skyepharma (SKYEF) for $620 Million to Create Powerful Respiratory Company 3/16/2016
Microlin Bio To Acquire Nucleic Acid Therapeutics Assets Of Marina Biotech, Inc. (MRNA) 3/16/2016
Sunshine Biopharma, Inc. Eliminates The Debt Obligations Associated With The Recently Acquired Patents For Its Adva-27a Anticancer Compound 3/16/2016
Top Five Allergan (AGN) Execs Could Get $300 Million Golden Parachutes Plus Another $86 Million Tax Break If They Lose Jobs 3/16/2016
Laurus Synthesis Acquires Reaction Optimization And Process Design Tools To Enhance Capabilities 3/15/2016
Bay Area Stemcentrx Up for Sale, With Hints of a Possible IPO 3/15/2016
HUYA Bioscience Acquires Exclusive Rights To Immuno-Oncology Products From Fudan University 3/15/2016
Washington University Acquires ViewRay Incorporated Research System To Investigate MRI-Guided Linac Capabilities 3/15/2016
Safeguard Scientifics (SFE) Partner Company Putney to be Acquired for $200 Million 3/15/2016
Strand Life Sciences, Venaxis (APPY) Terminate Merger Plans 3/15/2016